Organon (OGN) Fundamental Analysis: Revenue, Earnings & Valuation

1.82 / 10

Underperform

Fundamental rating is Underperform, with a 1.8/10 health score. Inventory turnover and interest coverage are strong, but long‑term debt to working capital and YoY revenue decline are concerning. Overall, the fundamentals are weak, indicating prudence.

Analysis Checks(5/10)

Revenue-MV

Value1.84

Score2/3

Weight30.63%

1M Return4.88%

Total operating revenue (YoY growth rate %)

Value-2.92

Score1/3

Weight-1.89%

1M Return-0.38%

Inventory turnover ratio

Value2.13

Score3/3

Weight-4.74%

1M Return-0.93%

Current liabilities / Total liabilities (%)

Value19.73

Score3/3

Weight8.97%

1M Return1.67%

PB-ROE

Value-0.92

Score1/3

Weight39.02%

1M Return7.56%

Long-term debt to working capital ratio (%)

Value4.96

Score1/3

Weight-3.24%

1M Return-0.65%

Interest coverage ratio (EBIT / Interest expense) (%)

Value1.84

Score2/3

Weight-5.60%

1M Return-1.17%

Operating revenue (YoY growth rate %)

Value-2.92

Score1/3

Weight-1.49%

1M Return-0.30%

Cost of sales ratio (%)

Value46.70

Score2/3

Weight-5.29%

1M Return-1.13%

Asset-MV

Value-0.55

Score1/3

Weight43.63%

1M Return6.31%

Is OGN undervalued or overvalued?

OGN scores 1.82/10 on fundamentals and holds a Premium valuation at present. Backed by its 30.56% ROE, 3.01% net margin, 8.55 P/E ratio, 2.13 P/B ratio, and -78.57% earnings growth, these metrics solidify its Underperform investment rating.